9258 Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,680
| Closed | -$201K | – | 329 |
|
|
2022
Q4 | $201K | Buy |
+1,680
| New | +$201K | 0.04% | 311 |
|
|
2021
Q4 | – | Sell |
-3,702
| Closed | -$355K | – | 375 |
|
|
2021
Q3 | $355K | Hold |
3,702
| – | – | 0.09% | 226 |
|
|
2021
Q2 | $360K | Buy |
3,702
+19
| +0.5% | +$1.85K | 0.1% | 221 |
|
|
2021
Q1 | $358K | Sell |
3,683
-71
| -2% | -$6.9K | 0.11% | 205 |
|
|
2020
Q4 | $360K | Buy |
3,754
+365
| +11% | +$35K | 0.12% | 194 |
|
|
2020
Q3 | $334K | Buy |
3,389
+91
| +3% | +$8.97K | 0.13% | 187 |
|
|
2020
Q2 | $402K | Buy |
3,298
+10
| +0.3% | +$1.22K | 0.16% | 156 |
|
|
2020
Q1 | $334K | Buy |
3,288
+156
| +5% | +$15.8K | 0.15% | 171 |
|
|
2019
Q4 | $337K | Buy |
+3,132
| New | +$337K | 0.12% | 204 |
|